A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder

Bipolar Disorders

Volumn 11, Issue 5, 2009, Pages 483-493

  Delbello, Melissa P ^a   Chang, Kiki ^b   Welge, Jeffrey A ^a   Adler, Caleb M ^a   Rana, Manasi ^b   Howe, Meghan ^b   Bryan, Holly ^a   Vogel, Daniel ^c   Sampang, Suzanne ^c   Delgado, Sergio V ^c   Sorter, Michael ^c   Strakowski, Stephen M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Adolescents; Bipolar disorder; Depression; Placebo; Quetiapine

Indexed keywords

PLACEBO; QUETIAPINE;

ADOLESCENT; ADULT; ARTICLE; BACKACHE; BEDTIME DOSAGE; BILIRUBIN BLOOD LEVEL; BIPOLAR I DISORDER; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; COMMON COLD SYMPTOM; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHAGIA; DYSPNEA; EXTRAPYRAMIDAL SYNDROME; FEMALE; GASTROINTESTINAL SYMPTOM; GLUCOSE BLOOD LEVEL; HAMILTON ANXIETY SCALE; HEART RATE; HUMAN; HYPERTENSION; INCREASED APPETITE; LIVER FUNCTION TEST; LOW DRUG DOSE; MALE; MANIA; MONOTHERAPY; NECK PAIN; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; REMISSION; SCORING SYSTEM; SEDATION; SIDE EFFECT; THORAX PAIN; TOOTH PAIN; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; XEROSTOMIA;

ADOLESCENT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; BODY WEIGHT; CHILD; DEPRESSION; DIBENZOTHIAZEPINES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METABOLOME; PILOT PROJECTS; PSYCHIATRIC STATUS RATING SCALES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 67749091140     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/j.1399-5618.2009.00728.x     Document Type: Article

References (32)

1. Goldstein TR, Birmaher B, Axelson D et al. History of suicide attempts in pediatric bipolar disorder: Factors associated with increased risk. Bipolar Disord 2005; 7: 525-535.
2. Strober M, Schmidt-Lackner S, Freeman R, Bower S, Lampert C, DeAntonio M. Recovery and relapse in adolescents with bipolar affective illness: A five-year naturalistic, prospective follow-up. J Am Acad Child Adolesc Psychiatry 1995; 34: 724-731.
3. Biederman J, Mick E, Spencer TJ, Wilens TE, Faraone SV. Therapeutic dilemmas in the pharmacotherapy of bipolar depression in the young. J Child Adolesc Psychopharmacol 2000; 10: 185-192.
4. Baumer FM, Howe M, Gallelli K, Simeonova DI, Hallmayer J, Chang KD. A pilot study of antidepressant-induced mania in pediatric bipolar disorder: Characteristics, risk factors, and the serotonin transporter gene. Biol Psychiatry 2006; 60: 1005-1012.
5. Chang KD, Saxena K, Howe M. An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006; 45: 298-304.
6. Poznanski EO, Cook SC, Carroll BJ. A depression rating scale for children. Pediatrics 1979; 64: 442-450.
7. Poznanski EO, Cook SC, Carroll BJ, Corzo H. Use of the Children's Depression Rating Scale in an inpatient psychiatric population. J Clin Psychiatry 1983; 44: 200-203.
8. Patel NC, DelBello MP, Bryan HS et al. Open-label lithium for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006; 45: 289-297.
9. Calabrese JR, Keck PE Jr, Macfadden W et al. A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005; 162: 1351-1360.
10. Thase ME, Macfadden W, Weisler RH et al. Efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind, placebo-controlled study (the BOLDER II study). J Clin Psychopharmacol 2006; 26: 600-609.
11. DelBello MP, Schwiers ML, Rosenberg HL, Strakowski SM. A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania. J Am Acad Child Adolesc Psychiatry 2002; 41: 1216-1223.
12. DelBello MP, Kowatch RA, Adler CM et al. A double-blind pilot study comparing quetiapine and divalproex for adolescent mania. J Am Acad Child Adolesc Psychiatry 2006; 45: 305-313.
13. DelBello MP, Adler CM, Whitsel RM, Stanford KE, Strakowski SM. A 12-week single-blind trial of quetiapine for the treatment of mood symptoms in adolescents at high risk for developing bipolar I disorder. J Clin Psychiatry 2007; 68: 789-795.
14. Kraemer HC, Mintz J, Noda A, Tinklenberg J, Yesavage JA. Caution regarding the use of pilot studies to guide power calculations for study proposals. Arch Gen Psychiatry 2006; 63: 484-489.
15. Geller B, Zimerman B, Williams M et al. Reliability of the Washington University in St. Louis Kiddie Schedule for Affective Disorders and Schizophrenia (WASH-U-KSADS) mania and rapid cycling sections. J Am Acad Child Adolesc Psychiatry 2001; 40: 450-455.
16. Brent D, Emslie G, Clarke G et al. Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: The TORDIA randomized controlled trial. JAMA 2008; 299: 901-913.
17. Hamilton M. Assessment of anxiety states by rating. Br J Med Psychol 1959; 32: 50-55.
18. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
19. Fristad MA, Weller EB, Weller RA. The Mania Rating Scale: Can it be used in children? A preliminary report. J Am Acad Child Adolesc Psychiatry 1992; 31: 252-257.
20. Leverich GS, Nolen WA, Rush AJ et al. The Stanley Foundation Bipolar Treatment Outcome Network. I. Longitudinal methodology. J Affect Disord 2001; 67: 33-44.
21. Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand (Suppl) 1970; 212: 11-19.
22. Barnes TR. A rating scale for drug-induced akathisia. Br J Psychiatry 1989; 154: 672-676.
23. Guy W. Abnormal Involuntary Movement Scale. ECDEU Assessment Manual for Psychopharmacology, revised edition. Rockville, MD: US Department of Health, Education, and Welfare, 1976.
24. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Hillsdale, NJ: Lawrence Erlbaum Associates, 1988.
25. Bridge JA, Birmaher B, Iyengar S, Barbe RP, Brent DA. Placebo response in randomized controlled trials of antidepressants for pediatric major depressive disorder. Am J Psychiatry 2009; 166: 42-49.
26. Geller B, Luby J. Child and adolescent bipolar disorder: A review of the past 10 years. J Am Acad Child Adolesc Psychiatry 1997; 36: 1168-1176.
27. Correll CU. Antipsychotic use in children and adolescents: Minimizing adverse effects to maximize outcomes. J Am Acad Child Adolesc Psychiatry 2008; 47: 9-20.
28. Kushner SF, Khan A, Lane R, Olson WH. Topiramate monotherapy in the management of acute mania: Results of four double-blind placebo-controlled trials. Bipolar Disord 2006; 8: 15-27.
29. DelBello MP, Findling RL, Kushner S et al. A pilot controlled trial of topiramate for mania in children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 2005; 44: 539-547.
30. Tohen M, Vieta E, Calabrese J et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003; 60: 1079-1088.
31. Geller B, Zimerman B, Williams M et al. Diagnostic characteristics of 93 cases of a prepubertal and early adolescent bipolar disorder phenotype by gender, puberty and comorbid attention deficit hyperactivity disorder. J Child Adolesc Psychopharmacol 2000; 10: 157-164.
32. Kowatch RA, Fristad M, Birmaher B, Wagner KD, Findling RL, Hellander M. Child Psychiatric Workgroup on Bipolar Disorder. Treatment guidelines for children and adolescents with bipolar disorder: Child Psychiatric Workgroup on Bipolar Disorder. J Am Acad Child Adolesc Psychiatry 2005; 44: 213-235.